Comparison of administration of GCSF daily versus every other day, in breast cancer patients' pain and cell blood counts
Phase 3
- Conditions
- Breast cancer.Malignant neoplasm of breast (Breast, unspecified)
- Registration Number
- IRCT2016101830363N1
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Sceince
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 93
Inclusion Criteria
female patients more than 20 years old with breast cancer
Exclusion criteria: Having no consent for taking apart in trial; History of Hypersensitivity to GCSF; Any active infection that may influence on cell blood counts; Patients more than 50 years old; Advanced renal or hepatic impairment or advanced cardiac disease that may have effect on cell blood count or patients ' symptoms and pain.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin. Timepoint: One week later. Method of measurement: Cell blood count test.;Platlet count. Timepoint: One week later. Method of measurement: Cell blood count test.;White blood cell count. Timepoint: One week later. Method of measurement: Cell blood count test.;Musculoskeletal pain. Timepoint: One week later. Method of measurement: McGill Pain Questionnaire.
- Secondary Outcome Measures
Name Time Method